Evolution of the Average Target: UBS Group AG

Evolution of the Target Price: UBS Group AG

Changes in Analyst Recommendations: UBS Group AG

fb3563502d90a1c6aaf913d2.F-yZt8T8yswG8z4jJby3jdgGCrwqPGGzuiHMfM4Y8yQ.I5qhjvbPnphPiU4VRPHRoIlqZ-ZlVVPB9BSDUZYppV5wodDD9YXytWqfWQ~08445863bbebc3a8ab4308fea01075f3
11:26am Microsoft's Fairwater AI Data Centers Driving Azure Growth, UBS Says MT
08:56am Auto1 Among Top MDax Performers as UBS Fuels Recovery DP
06:29am UBS AG : RBC gives a Buy rating ZD
01-22 Linde has 'Credible' Path to Boost Space Business, UBS Says MT
01-22 Southern Copper's Valuation Stretched, Production Set to Drop, UBS Says MT
01-21 Southern Copper Shares Lower After UBS Downgrade MT
01-21 Netflix's Q4 Results Driven by Member Growth, Higher Pricing, UBS Says MT
01-21 BofA Expects New Targets, Buybacks With UBS Group's Upcoming Q4 2025 Earnings Update MT
01-21 Swiss stocks - Factors to watch on January 21 RE
01-20 Kimberly-Clark Likely to Post 'Underwhelming' Q4, UBS Says MT
01-19 Ferrari: Analysts Remain Cautious, but the Stock Could Regain Momentum AN
01-16 Vail Resorts' Recent Visitation Data Was Steeper Than Expectations, UBS Says MT
01-16 Procter & Gamble's Fiscal Q2 Organic Growth Likely Muted, UBS Says MT
01-16 Tractor Supply's Q4 Results Unlikely to Move Shares, UBS Says MT
01-16 Novo's Wegovy pill makes encouraging start in weight-loss race vs Lilly RE
01-16 UBS Downgrades Sanofi, Citing Lack of "Pipeline" Zonebourse
01-15 VTEX Shares Fall After UBS Downgrade MT
01-15 Millicom International Cellular Shares Rise After UBS Upgrade MT
01-15 Sector Update: Health Care MT
01-15 CI&T Shares Rise After UBS Upgrade MT
01-15 GE Healthcare Faces Earnings Downside Risks, UBS Says MT
01-15 Entegris Could Benefit From Improving Industry Backdrop and Strong Semi Capex, UBS Says MT
01-15 UBS Reiterates Buy Rating on Danone Ahead of Results Zonebourse
01-15 Entegris shares hit highest since September 2024, last up 9% after UBS upgrade RE
01-15 Ge healthcare shares fall 2.1% after ubs downgrade RE
More recommendations

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
-4.11%
+16.38%
+8.02%
+16.41%
+10.33%
+7.33%
+28.87%
+11.79%
-4.44%
+17.38%
Average +10.80%
Weighted average by Cap. +9.82%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
37.93CHF
Average target price
36.37CHF
Spread / Average Target
-4.11%
High Price Target
48.00CHF
Spread / Highest target
+26.55%
Low Price Target
28.00CHF
Spread / Lowest Target
-26.18%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

BARCLAYS
JPMORGAN Kian Abouhossein
RBC Anke Reingen
DZ BANK Philipp Häßler
GOLDMAN SACHS Chris Hallam
RBC Capital Markets
BNP Paribas
alphavalue Pierre-Yves Gauthier
DEUTSCHE BANK RESEARCH Benjamin Goy
JEFFERIES Joseph Dickerson
Morgan Stanley
ODDO BHF
Keefe Bruyette
Kepler Cheuvreux
BERENBERG Peter Richardson
Citigroup
Axiom Capital Management
BofA Securities
CREDIT SUISSE Jon Peace
BNP Paribas Exane
Keefe, Bruyette & Woods
Exane BNP Paribas
DEUTSCHE BANK Benjamin Goy
Auriga
Jefferies & Co.
Deutsche Bank Securities
HSBC Piers Brown
BANK OF AMERICA (BOFA) Andrew Stimpson
BAADER BANK Tomasz Grzelak
MERRILL LYNCH Andrew Stimpson
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
37.93CHF
Average target price
36.37CHF
Spread / Average Target
-4.11%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. UBSG Stock
  4. Consensus UBS Group AG